Roburic acid

CAS No. 6812-81-3

Roburic acid( —— )

Catalog No. M18992 CAS No. 6812-81-3

Roburic acid and phenethyl-trans-ferulate inhibit COX-1 and COX-2.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 87 In Stock
10MG 170 In Stock
25MG 295 In Stock
50MG 444 In Stock
100MG 620 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Roburic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    Roburic acid and phenethyl-trans-ferulate inhibit COX-1 and COX-2.
  • Description
    Roburic acid and phenethyl-trans-ferulate inhibit COX-1 and COX-2.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    COX-1| COX-2
  • Research Area
    Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    6812-81-3
  • Formula Weight
    440.71
  • Molecular Formula
    C30H48O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 33.33 mg/mL (75.63 mM)
  • SMILES
    C(=O)(CC[C@]1([C@@H](CC[C@]2([C@@]3(CC[C@]4(CC[C@H]([C@@H]([C@H]4C3=CC[C@H]12)C)C)C)C)C)C(=C)C)C)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Cao H,et al. Discovery of cyclooxygenase inhibitors from medicinal plants used to treat inflammation. Pharmacol Res. 2010 Jun;61(6):519-24.
molnova catalog
related products
  • OV-1, sheep

    This alpha-helical antimicrobial OV-1 ovispirin peptide derived from SMAP29 peptide.It was found to inhibit several antibiotic-resistant bacterial strains including mucoid and nonmucoid Pseudomonas aeruginosa.

  • Lasalocid

    Lasalocid (Lasalocid-A) is an ion carrier antibiotic produced by Streptomyces, which has antimicrobial and parasitic properties and is often added to feed.

  • Garenoxacin mesylate...

    A quinolone antibiotic for the treatment of Gram-positive and Gram-negative bacterial infections.